You are here: Industry Insights > NMPA Approval

News List

First Generic Drugs Approved in China in 2022 Zhulikou/PharmaSources
February 15, 2023
List of the First Generic Drugs Approved in China in 2022
Weekly Pharma News Review | PharmaSources.com (April 11 to 15) Yefenghong
April 20, 2022
The sharp crushing in the stock prices of Chinese vaccine leader companies Zhifei Biological and Wantai Biological is the most-watched news this week.
Weekly Pharma News Review | PharmaSources.com （April.4th-April.8th） PharmaSources.com
April 12, 2022
This week, the release of Phase III clinical data for treating outpatients infected with mild and moderate COVID-19 with Kintor Pharmaceuticals' proxalutamide sparked an intense interest. The pharma news review of this week covers a total of 18 pieces of
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China prnasia
September 13, 2021
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products